Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Intersect Ent Inc (XENT)

Intersect Ent Inc (XENT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 395,651
  • Shares Outstanding, K 32,298
  • Annual Sales, $ 109,140 K
  • Annual Income, $ -42,990 K
  • 60-Month Beta 0.79
  • Price/Sales 3.76
  • Price/Cash Flow N/A
  • Price/Book 3.39

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.44
  • Number of Estimates 4
  • High Estimate -0.40
  • Low Estimate -0.47
  • Prior Year -0.35
  • Growth Rate Est. (year over year) -25.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.97 +94.97%
on 03/17/20
25.74 -54.78%
on 03/03/20
-12.22 (-51.22%)
since 02/28/20
3-Month
5.97 +94.97%
on 03/17/20
31.46 -63.00%
on 02/13/20
-13.25 (-53.23%)
since 12/27/19
52-Week
5.97 +94.97%
on 03/17/20
34.28 -66.04%
on 05/03/19
-20.51 (-63.79%)
since 03/29/19

Most Recent Stories

More News
Intersect ENT (XENT) Down 49.5% Since Last Earnings Report: Can It Rebound?

Intersect ENT (XENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

XENT : 11.64 (-4.98%)
Shares of Intersect Ent In Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (XENT , ZGNX , RVNC , ITCI , LCI )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

XENT : 11.64 (-4.98%)
RVNC : 15.35 (-1.54%)
ZGNX : 25.58 (+9.50%)
XENT Long Term Shareholder Alert: Johnson Fistel Investigates Intersect ENT, Inc.; Should Management be Held Accountable for Investors Losses?

Johnson Fistel, LLP is investigating potential claims on behalf of Intersect ENT, Inc. (NASDAQ: XENT) ("Intersect" or the "Company") against certain of its officers and directors.

XENT : 11.64 (-4.98%)
New Strong Sell Stocks for March 16th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

PEB : 10.53 (-1.13%)
FANG : 23.59 (-1.17%)
XENT : 11.64 (-4.98%)
DKL : 9.09 (+1.79%)
INVE : 3.25 (+0.93%)
Intersect Ent In has the Best Relative Performance in the Pharmaceuticals Industry (XENT , AERI , PFE , ZGNX , BMY )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

AERI : 13.49 (+3.37%)
XENT : 11.64 (-4.98%)
PFE : 32.67 (+5.73%)
Ocular Therapeut is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (OCUL , XENT , LLY , ITCI , PRGO )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

LLY : 138.44 (+3.23%)
XENT : 11.64 (-4.98%)
OCUL : 4.95 (+0.61%)
Intersect ENT Down on Low Propel Sales, Pricing Pressure

Intersect ENT (XENT) registers dull Propel performance on poor unit sales in Q4.

MDT : 91.50 (+1.79%)
RMD : 154.21 (+8.64%)
HRC : 101.58 (+2.06%)
XENT : 11.64 (-4.98%)
XENT Alert: Johnson Fistel Continues Investigation of Intersect ENT, Inc.; Should Management be Held Accountable for Investors Losses?

Johnson Fistel, LLP is investigating potential claims on behalf of Intersect ENT, Inc. (NASDAQ: XENT) ("Intersect" or the "Company") against certain of its officers and directors.

XENT : 11.64 (-4.98%)
Implied Volatility Surging for Intersect ENT (XENT) Stock Options

Investors need to pay close attention to Intersect ENT (XENT) stock based on the movements in the options market lately.

XENT : 11.64 (-4.98%)
Intersect ENT (XENT) Reports Narrower-Than-Expected Q4 Loss

Intersect ENT (XENT) exhibits a dismal performance in the fourth quarter of 2019.

SYK : 162.96 (+2.35%)
RMD : 154.21 (+8.64%)
STE : 139.99 (+7.90%)
XENT : 11.64 (-4.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Trade XENT with:

Business Summary

Intersect ENT, Inc. is a commercial drug-device company. The Company's initial products, PROPEL and PROPEL mini, are drug-eluting implants for use in patients with chronic sinusitis. It offers products and therapies for ear, nose, and throat surgeons to improve treatment for their patients with chronic...

See More

Key Turning Points

2nd Resistance Point 13.07
1st Resistance Point 12.66
Last Price 11.64
1st Support Level 11.69
2nd Support Level 11.13

See More

52-Week High 34.28
Fibonacci 61.8% 23.47
Fibonacci 50% 20.13
Fibonacci 38.2% 16.78
Last Price 11.64
52-Week Low 5.97

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar